---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-026298"
form_type: "8-K"
ticker: "ORKA"
cik: "0000907654"
company_name: "Oruka Therapeutics, Inc."
filed_at: "2022-12-09T23:59:59+00:00"
generated_at: "2026-06-21T07:12:46.648810+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# ARCA biopharma awards $100K retention bonuses and 40K RSUs each to COO Keuer and CFO Dekker

## Summary
- COO Thomas Keuer and CFO C. Jeffrey Dekker each receive $100,000 cash retention bonus and 40,000 RSUs.
- RSUs vest one year from December 8, 2022, subject to continued employment.
- Cash bonus payable upon earlier of a change in control or certain clinical development decisions by the Board.
- Unvested RSUs accelerate upon change in control or involuntary termination without cause or for good reason.
- Retention incentives designed to retain executives through key corporate milestones.

## SEC filing metadata
- accession: 0000950170-22-026298
- form_type: 8-K
- ticker: ORKA
- cik: 0000907654
- company_name: Oruka Therapeutics, Inc.
- filed_at: 2022-12-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/907654/000095017022026298/0000950170-22-026298-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/907654/000095017022026298/abio-20221208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-026298
- JSON: https://secwatch.observer/filing/0000950170-22-026298.json
- Plain text: https://secwatch.observer/filing/0000950170-22-026298.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.